Nicholas Voss

1.5k total citations
37 papers, 1.1k citations indexed

About

Nicholas Voss is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Nicholas Voss has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 10 papers in Genetics. Recurrent topics in Nicholas Voss's work include Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Nicholas Voss is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Nicholas Voss collaborates with scholars based in Canada and United States. Nicholas Voss's co-authors include Joseph M. Connors, Randy D. Gascoyne, Richard Klasa, Kerry J. Savage, Joel B. Epstein, Peter Stevenson‐Moore, N. Al-Rajhi, John D. Shepherd, R.N. Fairey and Donna E. Hogge and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Nicholas Voss

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Voss Canada 16 823 512 399 289 160 37 1.1k
Georg Mann Austria 13 835 1.0× 397 0.8× 397 1.0× 205 0.7× 159 1.0× 17 1.3k
F. Boissevain Germany 7 1.0k 1.2× 655 1.3× 467 1.2× 235 0.8× 283 1.8× 8 1.2k
D.P. Deakin United Kingdom 21 755 0.9× 449 0.9× 236 0.6× 284 1.0× 294 1.8× 40 1.2k
Joseph M. Connors Canada 6 620 0.8× 387 0.8× 251 0.6× 225 0.8× 141 0.9× 7 764
J R Anderson United States 13 881 1.1× 603 1.2× 170 0.4× 261 0.9× 114 0.7× 21 1.3k
Alice Di Rocco Italy 16 775 0.9× 466 0.9× 317 0.8× 270 0.9× 135 0.8× 64 1.1k
Caterina Patti Italy 19 1.4k 1.6× 608 1.2× 458 1.1× 282 1.0× 358 2.2× 75 1.7k
Jun‐ichi Tamaru Japan 15 822 1.0× 545 1.1× 402 1.0× 350 1.2× 42 0.3× 27 1.0k
Gregory Bociek United States 14 562 0.7× 379 0.7× 131 0.3× 230 0.8× 174 1.1× 35 836
Rie Hyo Japan 14 977 1.2× 763 1.5× 273 0.7× 277 1.0× 45 0.3× 27 1.2k

Countries citing papers authored by Nicholas Voss

Since Specialization
Citations

This map shows the geographic impact of Nicholas Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Voss more than expected).

Fields of papers citing papers by Nicholas Voss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Voss. The network helps show where Nicholas Voss may publish in the future.

Co-authorship network of co-authors of Nicholas Voss

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Voss. A scholar is included among the top collaborators of Nicholas Voss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Voss. Nicholas Voss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramadan, Khaled M. A., Joseph M. Connors, Abdulwahab J. Al-Tourah, et al.. (2008). Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results. Bone Marrow Transplantation. 42(9). 601–608. 14 indexed citations
2.
Al-Tourah, Abdulwahab J., Karamjit Gill, Paul Hoskins, et al.. (2006). The impact of initial treatment of advanced stage indolent lymphoma on the risk of transformation. Journal of Clinical Oncology. 24(18_suppl). 7510–7510. 12 indexed citations
3.
Song, Kevin, Michael J. Barnett, Randy D. Gascoyne, et al.. (2006). Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma*. British Journal of Haematology. 133(6). 634–637. 13 indexed citations
4.
5.
6.
Toze, Cynthia L., Joseph M. Connors, Thomas J. Nevill, et al.. (2005). Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma*. British Journal of Haematology. 131(2). 223–230. 65 indexed citations
7.
Toze, Cynthia L., Michael J. Barnett, John D. Shepherd, et al.. (2005). Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease. Bone Marrow Transplantation. 36(9). 825–830. 53 indexed citations
8.
Savage, Kerry J., N. Al-Rajhi, Nicholas Voss, et al.. (2005). Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Annals of Oncology. 17(1). 123–130. 179 indexed citations
9.
Shenkier, Tamara, Nicholas Voss, Mukesh Chhanabhai, et al.. (2005). The treatment of primary central nervous system lymphoma in 122 immunocompetent patients. Cancer. 103(5). 1008–1017. 30 indexed citations
10.
Lavoie, Julye C., Joseph M. Connors, Gordon L. Phillips, et al.. (2005). High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver. Blood. 106(4). 1473–1478. 83 indexed citations
11.
Toze, Cynthia L., Michael J. Barnett, Joseph M. Connors, et al.. (2004). Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation. British Journal of Haematology. 127(3). 311–321. 34 indexed citations
12.
Song, Kevin, Thomas J. Nevill, Randy D. Gascoyne, et al.. (2004). Hematopoietic Stem Cell Transplant (HSCT) as Primary Treatment for T-Cell Lymphobastic Lymphoma (T-LBL) : An Intention to Treat Analysis.. Blood. 104(11). 900–900. 1 indexed citations
13.
Leitch, Heather A., Randy D. Gascoyne, Mukesh Chhanabhai, et al.. (2003). Limited-stage mantle-cell lymphoma. Annals of Oncology. 14(10). 1555–1561. 68 indexed citations
14.
Maguire, J., et al.. (2002). Intra-cerebral Relapse Following Prolonged Remission after Autologous Stem Cell Transplantation for Multiple Myeloma. Leukemia & lymphoma. 43(12). 2399–2403. 3 indexed citations
15.
Voss, Nicholas & Charmaine Kim‐Sing. (1998). RADIOTHERAPY IN THE TREATMENT OF DERMATOLOGIC MALIGNANCIES. Dermatologic Clinics. 16(2). 313–320. 20 indexed citations
16.
El‐Khatib, Ellen, et al.. (1995). Variation of electron beam uniformity with beam angulation and scatterer position for total skin irradiation with the stanford technique. International Journal of Radiation Oncology*Biology*Physics. 33(2). 469–474. 31 indexed citations
17.
Grafton, C., Stephen Lam, Nicholas Voss, et al.. (1991). High dose rate endobronchial brachytherapy using the microselectron. Lung Cancer. 7. 97–97. 2 indexed citations
18.
19.
20.
Connors, Joseph M., Paul Klimo, Nicholas Voss, R.N. Fairey, & Sharon Jackson. (1988). Testicular lymphoma: improved outcome with early brief chemotherapy.. Journal of Clinical Oncology. 6(5). 776–781. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georg Mann Breakdown of academic impact, for papers by F. Boissevain Breakdown of academic impact, for papers by D.P. Deakin Breakdown of academic impact, for papers by Joseph M. Connors Breakdown of academic impact, for papers by J R Anderson Breakdown of academic impact, for papers by Alice Di Rocco Breakdown of academic impact, for papers by Caterina Patti Breakdown of academic impact, for papers by Jun‐ichi Tamaru Breakdown of academic impact, for papers by Gregory Bociek Breakdown of academic impact, for papers by Rie Hyo
Rankless by CCL
2026